ZMB Members
ZMB Members
Member list
The ZMB currently comprises approx. 80 research groups from the Faculties of Biology, Medicine, and Chemistry at the Essen Campus and the University Hospital Essen, as well as groups from the Max Planck Institute of Molecular Physiology in Dortmund. If you are interested in participating in the ZMB network, please do not hesitate to contact us!
Search for members
member(s)
Prof. Dr.Stephan Barcikowski
Group: Technical Chemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Peter Bayer
Group: Structural and Medicinal Biochemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr. Dr.Jürgen Becker
Group: Translational Skin Cancer Research
ZMB Research Program: Oncology
More
Prof. Dr.Ivo Bendix
Group: Experimental Perinatal Neuroscience
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Dominik Boos
Group: Molecular Genetics II
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr. Dana Branzei
Group: Biological and Genomic Treatment Approaches
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Jan Buer
Director of: Institute of Medical Microbiology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Ulf Dittmer
Director of: Institute of Virology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Nicole Dünker
Group: Neuroanatomy
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Michael Ehrmann
Group: Microbiology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Matthias Epple
Group: Inorganic Chemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Kai Exner
Group: Theoretical Inorganic Chemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Joachim Fandrey
Director of: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Katharina Fleischhauer
Director of: Institute for Experimental Cellular Therapy
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Stefanie Flohé
Group: Immunology Sepsis/Trauma
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Dagmar Führer-Sakel
Director of: Clinic for Endocrinology, Diabetology and Metabolism
ZMB Research Program: Oncology
More
Prof. Dr.Anzhela Galstyan
Group: Photoactive Nanomaterials
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Bernd Giebel
Group: Giebel Lab
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Barbara M. Grüner
Group: Cell Plasticity and Metastasis
ZMB Research Program: Oncology
More
Prof. Dr.Barbara Grünwald
Group: Tumor Heterogeneity and Translational Systems Biology
ZMB Research Program: Oncology
More
Prof. Dr.Erich Gulbins
Director of: Department of Molecular Biology
ZMB Research Program: Oncology
More
Prof. Dr.Matthias Gunzer
Director of: Institute of Experimental Immunology & Imaging
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Wiebke Hansen
Group: Molecular Infection Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Sven Heiles
Group: Lipidomics
ISAS e.V., Dortmund
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Doris Hellerschmied-Jelinek
Group: Mechanistic Cell Biology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Ulrike Hendgen-Cotta
Manager of: Cardio Science Labs
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Dirk M. Hermann
Group: Vascular Neurology, Dementia and Age Research
ZMB Research Program: Molecular and Chemical Cell Biology
More
PD Dr.Josephine Herz
Group: Experimental Perinatal Neuroscience
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Heike Heuer
Group: Molecular Thyroidology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Anke Hinney
Group: LVR Clinic for Psychiatry Essen
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Daniel Hoffmann
Group: Bioinformatics and Computational Biophysics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Peter Horn
Director of: Institute for Transfusion Medicine
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr. Dr. h.c. mult.Robert Huber
Group: Structure Research
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Hans Werner Ingensiep
Group: Institute of Philosophy
Faculty of Humanities
University of Duisburg-Essen
More
Prof. Dr.Christian Johannes
Group: Molecular Genetics I
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Markus Kaiser
Group: Chemical Biology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Farnusch Kaschani
Manager of: Analytics Core Facility Essen (ACE)
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Carsten Kirschning
Group: Regulation of Pathogen-specific Immunity
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Diana Klein
Group: Vascular Remodeling & Normal Tissue Protection
ZMB Research Program: Oncology
More
Prof. Dr.Christoph Kleinschnitz
Director of: Clinic for Neurology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Shirley Knauer
Group: Molecular Biology II
ZMB Research Program: Molecular and Chemical Cell Biology
More
PD Dr.Adalbert Krawczyk
Group: Clinic for Infectious Diseases
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Ralf Küppers
Director of: Institute of Cell Biology (Tumor Research)
ZMB Research Program: Oncology
More
Prof. Dr.Karl Sebastian Lang
Director of: Institute of Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Jun.-Prof. Dr.Elisabeth Littwitz-Salomon
Group: Immune Metabolism in Infection and Cancer
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Dietmar Lohmann
Group: Ophthalmic Oncology and Genetics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Katharina Lückerath
Group: Preclinical Theranostics in Nuclear Medicine
ZMB Research Program: Oncology
More
Prof. Dr.Hemmo Meyer
Group: Molecular Biology I
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Andrea Musacchio
Group: Mechanistic Cell Biology
Max Planck Institute of Molecular Physiology
Dortmund
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Perihan Nalbant
Group: Molecular Cell Biology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Jochen Niemeyer
Group: Supramolecular Organocatalysis and Chemosensing
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Samuel Peña-Llopis
Junior Group: Translational Genomics in Solid Tumors
ZMB Research Program: Oncology
More
Prof. Dr.Alexander Probst
Group: Environmental Metagenomics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Luisa Rajcsanyi
Group: Molecular Genetics of Mental Disorders
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Tienush Rassaf
Director of: Clinic for Cardiology and Vascular Medicine
ZMB Research Program: Oncology
More
Prof. Dr.Stefan Raunser
Group: Structural Biochemistry
Max Planck Institute of Molecular Physiology
Dortmund
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Christian Reinhardt
Director of: Clinic for Hematology and Stem Cell Transplantation
ZMB Research Program: Oncology
More
Prof. Dr.Alexander Roesch
Group: Tumor Heterogeneity & Plasticity
ZMB Research Program: Oncology
More
Prof. Dr.Barbara Saccà
Group: Bionanotechnology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Sebastian Schlücker
Group: Molecular Biophotonics and Nanodiagnostics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Thomas Schrader
Group: Biosupramolecular Chemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Martin Schuler
Director of: Department of Medical Oncology
ZMB Research Program: Oncology
More
Dr.Nina Schulze
Manager of: Imaging Center Essen (ICCE)
ZMB Research Program: Molecular and Chemical Cell Biology
More
Jun.-Prof. Dr.Katja Siebecke
Group: Institute of Physiology
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof Dr.Bettina Siebers
Group: Molecular Enzyme Technology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Winfried Siffert
Director of: Institute of Pharmacogenetics
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr. Dr.Jens Siveke
Group: Bridge Institute for Experimental Tumor Therapy
ZMB Research Program: Oncology
More
PD Dr.Kathrin Sutter
TRR60 Junior Research Group: Interferone-alpha Subtypes
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Kathrin Thedieck
Group: Metabolism, Senescence and Autophagy
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Silvia Vega-Rubín-de-Celis
Junior Research Group: Autophagy in Cancer
ZMB Research Program: Oncology
More
Prof. Dr.Andrea Vortkamp
Group: Developmental Biology
ZMB Research Program: Molecular and Chemical Cell Biology
More
PD Dr.Jens Voskuhl
Group: Biosupramolecular Chemistry
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Gunther Wennemuth
Director of: Institute of Anatomy
ZMB Research Program: Molecular and Chemical Cell Biology
More
Prof. Dr.Astrid Westendorf
Group: Infection Immunology
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Prof. Dr.Stefan Westermann
Group: Molecular Genetics I
ZMB Research Program: Molecular and Chemical Cell Biology
More
Dr.Florian Wirsdörfer
Group: Immunomodulation
ZMB Research Program: Immunology, Infectious Diseases and Transplantation
More
Dr.Manuela Wülling
Group: Developmental Biology
ZMB Research Program: Molecular and Chemical Cell Biology
MoreCurrent Selected Publications
Biology
-
A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrilsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 2992DOI (Open Access)
-
ATXN3 regulates lysosome regeneration after damage by targeting K48-K63-branched ubiquitin chainsIn: The EMBO Journal, Vol. 44, 2025, Nr. 18, pp. 5086 – 5111DOI (Open Access)
-
Bacterial pathogen deploys the iminosugar glycosyrin to manipulate plant glycobiologyIn: Science, Vol. 388, 2025, Nr. 6744, pp. 297 – 303
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Interplay of kinetochores and catalysts drives rapid assembly of the mitotic checkpoint complexIn: Nature Communications, Vol. 16, 2025, Nr. 1, 4823DOI (Open Access)
-
Lack of AtMC1 catalytic activity triggers autoimmunity dependent on NLR stabilityIn: EMBO Reports, Vol. 26, 2025, Nr. 9, pp. 2378 – 2412DOI (Open Access)
-
Light-Activatable Ubiquitin for Studying Linkage-Specific Ubiquitin Chain Formation KineticsIn: Advanced Science, Vol. 12, 2025, Nr. 6, 2406570DOI (Open Access)
-
Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicityIn: Nature Communications, Vol. 16, 2025, Nr. 1, 2110DOI (Open Access)
-
Multistate kinetics of the syringe-like injection mechanism of Tc toxinsIn: Science Advances, Vol. 11, 2025, Nr. 1, eadr2019DOI (Open Access)
-
Muscle growth by sarcomere divisionsIn: Science Advances, Vol. 11, 2025, Nr. 28, eadw9445DOI (Open Access)
-
Small Molecule-Induced Alterations of Protein Polyubiquitination Revealed by Mass-Spectrometric Ubiquitome AnalysisIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 32, e202508916DOI (Open Access)
-
Structural basis for TIR domain–mediated innate immune signaling by Toll-like receptor adaptors TRIF and TRAMIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS), Vol. 122, 2025, Nr. 2, e2418988122DOI (Open Access)
-
Sulphostin-inspired N-phosphonopiperidones as selective covalent DPP8 and DPP9 inhibitorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3208DOI (Open Access)
-
The BUB1 and BUBR1 paralogs scaffold the kinetochore fibrous coronaIn: Science Advances, Vol. 11, 2025, Nr. 37, eady6890DOI (Open Access)
-
The Spc105/Kre28 complex promotes mitotic error correction by outer kinetochore recruitment of Ipl1/Sli15In: The EMBO Journal, Vol. 44, 2025, Nr. 12, pp. 3492 – 3520DOI (Open Access)
-
Trypstatin as a Novel TMPRSS2 Inhibitor with Broad-Spectrum Efficacy against Corona and Influenza VirusesIn: Advanced Science, Vol. 12, 2025, Nr. 25, 2506430DOI (Open Access)
Journal articles
Current Selected Publications
Chemistry
-
A roadmap for equitable reuse of public microbiome dataIn: Nature Microbiology, Vol. 10, 2025, Nr. 10, pp. 2384 – 2395
-
Author Correction: A roadmap for equitable reuse of public microbiome dataIn: Nature Microbiology, 2025, in pressDOI (Open Access)
-
CCooperative Active Sites on Ag2Pt3TiS6 for Enhanced Low-Temperature Ammonia Fuel Cell ElectrocatalysisIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 6, e202418691 , in pressDOI (Open Access)
-
In situ Cyclization of Aromatic Thioethers in Emissive Materials to Generate Phosphorescent DibenzothiophenesIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 2, e202414326DOI (Open Access)
-
Interfacing with the Brain : How Nanotechnology Can ContributeIn: ACS Nano, Vol. 19, 2025, Nr. 11, pp. 10630 – 10717DOI (Open Access)
-
Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in miceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3933DOI (Open Access)
-
Oxygen evolution reaction on IrO₂(110) is governed by Walden-type mechanismsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 6137DOI (Open Access)
-
Renaissance of Chlorine Evolution Reaction : Emerging Theory and Catalytic MaterialsIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 1, e202417293DOI (Open Access)
-
Selectivity Control in the Nitrogen Reduction Reaction over Mo₂C MXene by a Nitrogen-Rich EnvironmentIn: ACS Catalysis, Vol. 15, 2025, pp. 5589 – 5600DOI (Open Access)
-
Single-Atom Centers of MXenes for Electrochemical Ammonia Oxidation : Moving Beyond Thermodynamic DescriptorsIn: ACS Catalysis, Vol. 15, 2025, Nr. 18, pp. 16208 – 16220DOI (Open Access)
-
Surface-enhanced Raman spectroscopy : a half-century historical perspectiveIn: Chemical Society Reviews, Vol. 54, 2025, Nr. 3, pp. 1453 – 1551DOI (Open Access)
Journal articles
Current Selected Publications
Medicine
-
Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophreniaIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 7, pp. 2891 – 2906DOI (Open Access)
-
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityIn: Cancer Cell, Vol. 43, 2025, Nr. 2, pp. 269 – 291.e19DOI (Open Access)
-
Adjuvant nivolumab and relatlimab in stage III/IV melanoma : the randomized phase 3 RELATIVITY-098 trialIn: Nature Medicine, 2025, in pressDOI (Open Access)
-
Advances and challenges in precision imagingIn: The Lancet Oncology, Vol. 26, 2025, Nr. 1, pp. e34 – e45
-
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 1, pp. 152 – 164DOI (Open Access)
-
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphomaIn: Nature Communications, Vol. 16, 2025, Nr. 1, 4967DOI (Open Access)
-
CSF1R⁺ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphomaIn: Cancer Cell, Vol. 43, 2025, Nr. 8, pp. 1476 – 1494.e10DOI (Open Access)
-
Clinical validation of droplet digital PCR assays in detecting BRAFV⁶⁰⁰-mutant circulating tumour DNA as a prognostic biomarker in patients with resected stage III melanoma receiving adjuvant therapy (COMBI-AD) : A biomarker analysis from a double-blind, randomised phase 3 trialIn: The Lancet Oncology, Vol. 26, 2025, Nr. 5, pp. 641 – 653
-
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemiaIn: Blood, Vol. 145, 2025, Nr. 17, pp. 1943 – 1956
-
Common origin and somatic mutation patterns of composite lymphomas and leukemiasIn: Leukemia, Vol. 39, 2025, Nr. 8, pp. 1960 – 1971DOI (Open Access)
-
Constitutive expression of the transcriptional co-activator IκBζ promotes melanoma growth and immunotherapy resistanceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 5387DOI (Open Access)
-
Correction to: Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumoursIn: Nature, Vol. 639, 2025, Nr. 8054, pp. E18DOI (Open Access)
-
Cutaneous melanoma : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upIn: Annals of Oncology, Vol. 36, 2025, Nr. 1, pp. 10 – 30
-
Diet modulates the therapeutic effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCAR2In: eLife, Vol. 14, 2025, e98970DOI (Open Access)
-
Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 789DOI (Open Access)
-
Exercise facilitates post-stroke recovery through mitigation of neuronal hyperexcitability via interleukin-10 signalingIn: Nature Communications, Vol. 16, 2025, Nr. 1, 8928DOI (Open Access)
-
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non-Small Cell Lung CancerIn: Clinical Cancer Research, Vol. 31, 2025, Nr. 5, pp. 801 – 807
-
Final overall survival and safety analyses of the phase III PSMAfore trial of [¹⁷⁷Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology, Vol. 36, 2025, Nr. 11, pp. 1319 – 1330DOI (Open Access)
-
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 392, 2025, Nr. 1, pp. 11 – 22DOI, Online Full Text (Open Access)
-
Fulminant myocarditis : outcome predictors in an international cohort studyIn: European Heart Journal, 2025, in press
-
Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8087, pp. 1243 – 1253DOI (Open Access)
-
Gemtuzumab ozogamicin in first-line treatment of CBF-AML : Insights from a retrospective multi-center analysisIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2174 – 2180DOI (Open Access)
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 5, pp. 1836 – 1846DOI (Open Access)
-
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2215 – 2225DOI (Open Access)
-
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment : A Consensus ReviewIn: JAMA Oncology, 2025, in press
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Hypoxic-ischemic brain injury in neonatal mice sequentially recruits neutrophils with dichotomous phenotype and functionIn: Nature Communications, Vol. 16, 2025, Nr. 1, 9696DOI (Open Access)
-
IL-10 sensing by lung interstitial macrophages prevents bacterial dysbiosis-driven pulmonary inflammation and maintains immune homeostasisIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1306 – 1326.e7DOI (Open Access)
-
Immune training enhances anti-viral responses and improves outcomes in Pax5−/⁺ mice susceptible to chronic infectionIn: EMBO Molecular Medicine, Vol. 17, 2025, Nr. 4, pp. 696 – 721DOI (Open Access)
-
Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolutionIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1343 – 1358.e13DOI (Open Access)
-
Influence of Resuscitated Cardiac Arrest on Efficacy and Safety of Extracorporeal Life Support in Infarct-Related Cardiogenic Shock : A Substudy of the ECLS-SHOCK TrialIn: Circulation, Vol. 151, 2025, Nr. 24, pp. 1752 – 1754
-
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancerIn: Nature Medicine, Vol. 31, 2025, Nr. 8, pp. 2755 – 2767DOI (Open Access)
-
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanomaIn: Annals of Oncology, Vol. 36, 2025, Nr. 10, pp. 1166 – 1177DOI (Open Access)
-
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice : An international surveyIn: The Lancet Oncology, Vol. 26, 2025, Nr. 1, pp. 12 – 14
-
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaIn: Cell Reports, Vol. 44, 2025, Nr. 4, 115541DOI (Open Access)
-
Publisher Correction : Functional synapses between neurons and small cell lung cancerIn: Nature, Vol. 646, 2025, Nr. 8086, pp. E17DOI (Open Access)
-
Retraction note: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistanceIn: Nature, Vol. 647, 2025, pp. 544DOI (Open Access)
-
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivoIn: EMBO Molecular Medicine, 2025, in pressDOI (Open Access)
-
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II ActivityIn: Cancer Research, Vol. 85, 2025, Nr. 5, pp. 942 – 955DOI (Open Access)
-
Subgrouping germinal center-derived B-cell lymphomas based on machine learning-deduced DNA methylation modulesIn: Leukemia, Vol. 39, 2025, Nr. 4, pp. 967 – 971DOI (Open Access)
-
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based ChemotherapyIn: The New England Journal of Medicine, Vol. 393, 2025, Nr. 4, pp. 349 – 361
-
The Lung Cancer Autochthonous Model Gene Expression Database Enables Cross-Study Comparisons of the Transcriptomic Landscapes Across Mouse ModelsIn: Cancer Research, Vol. 85, 2025, Nr. 10, pp. 1769 – 1783
-
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAIn: eLife, Vol. 14, 2025, e96414DOI, Online Full Text (Open Access)
-
Transcription factor switching drives subtype-specific pancreatic cancerIn: Nature Genetics, 2025, in pressDOI (Open Access)
-
Unraveling Relatlimab-Specific Biology Using Biomarker Analyses in Patients with Advanced Melanoma in RELATIVITY-047In: Clinical Cancer Research, Vol. 31, 2025, Nr. 17, pp. 3702 – 3714DOI (Open Access)
-
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsIn: Leukemia, Vol. 39, 2025, Nr. 10, pp. 2523 – 2532DOI (Open Access)
-
[⁶⁸Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation : A single-centre, single-arm, interventional, phase 2 trialIn: The Lancet Oncology, Vol. 26, 2025, Nr. 9, pp. 1204 – 1214DOI (Open Access)
-
msiFlow : automated workflows for reproducible and scalable multimodal mass spectrometry imaging and microscopy data analysisIn: Nature Communications, Vol. 16, 2025, Nr. 1, 1065DOI (Open Access)